Try our Advanced Search for more refined results
Nostrum Laboratories Inc.
-
Response | Filed: May 31, 2024 | Entered: May 31, 2024 Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. et al
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Brief - Reply
REPLY BRIEF re 887 MOTION to Strike HEC's Motion for Recovery of Damges Under the Injunction Bond filed by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra)
-
Misc | Filed: May 29, 2024 | Entered: May 30, 2024 IN RE: ZANTAC (RANITIDINE) PRODUCTS LIABILITY LITIGATION
Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability | Florida Southern
Letter
Letter to the Court Regarding Settlement from James Dow Vandivere. (jas)
-
Response | Filed: May 30, 2024 | Entered: May 30, 2024 IN RE: ZANTAC (RANITIDINE) PRODUCTS LIABILITY LITIGATION
Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability | Florida Southern
Reply to Response to Motion
REPLY to Response to Motion re 7294 MOTION to Remand to State Court Plaintiff Jorge Contreras filed by Ashley C Keller. (Attachments: # 1 Exhibit 5, # 2 Exhibit 6)(Keller, Ashley)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login